Details

Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population, CCDR 51(2/3) - Canada.ca

Metadata and links for an archived snapshot.

Source: Public Health Agency of Canada
Date: Mar 7, 2026 · edition #7
Timestamp: 2026-03-07T15:17:18.566Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2025-51/issue-2-3-february-march-2025/comparison-13-15-20-valent-pneumococcal-conjugate-vaccines-paediatric-canadian-population.html
Replay URL: https://replay.healtharchive.ca/job-7/20260307151718/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2025-51/issue-2-3-february-march-2025/comparison-13-15-20-valent-pneumococcal-conjugate-vaccines-paediatric-canadian-population.html#ha_snapshot=774740
ID: 774740
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots